IRIS
DE STEFANO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.944
EU - Europa 18.244
AS - Asia 3.808
OC - Oceania 43
AF - Africa 39
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 24
Totale 48.129
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.887
GB - Regno Unito 6.129
IE - Irlanda 3.146
CN - Cina 2.242
UA - Ucraina 1.979
IT - Italia 1.418
RU - Federazione Russa 1.315
SE - Svezia 1.314
FR - Francia 1.029
DE - Germania 935
HK - Hong Kong 646
SG - Singapore 568
FI - Finlandia 499
ES - Italia 128
VN - Vietnam 117
BE - Belgio 83
TR - Turchia 76
NL - Olanda 57
CA - Canada 50
AU - Australia 34
CZ - Repubblica Ceca 32
IN - India 30
RO - Romania 27
CI - Costa d'Avorio 25
MK - Macedonia 25
JP - Giappone 24
EU - Europa 23
IR - Iran 23
PH - Filippine 20
AT - Austria 18
IL - Israele 16
RS - Serbia 14
CH - Svizzera 13
GR - Grecia 12
BR - Brasile 11
BG - Bulgaria 10
NZ - Nuova Zelanda 9
HU - Ungheria 8
MD - Moldavia 8
PL - Polonia 8
CL - Cile 6
LU - Lussemburgo 6
MA - Marocco 6
AR - Argentina 5
KR - Corea 5
KZ - Kazakistan 5
NO - Norvegia 5
SA - Arabia Saudita 5
EG - Egitto 4
ID - Indonesia 4
AL - Albania 3
DK - Danimarca 3
HR - Croazia 3
LK - Sri Lanka 3
LT - Lituania 3
MX - Messico 3
PA - Panama 3
PK - Pakistan 3
TH - Thailandia 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CO - Colombia 2
EE - Estonia 2
IM - Isola di Man 2
LV - Lettonia 2
PT - Portogallo 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 48.129
Salva come PNG Salva come JPEG
Città #
Southend 5.637
Fairfield 4.003
Dublin 3.132
Houston 3.030
Chandler 1.954
Ashburn 1.942
Woodbridge 1.917
Jacksonville 1.653
Wilmington 1.583
Seattle 1.561
Cambridge 1.390
Menlo Park 1.283
Princeton 752
Ann Arbor 708
Nanjing 558
Siena 466
Beijing 434
Singapore 332
Boardman 273
San Mateo 258
San Diego 215
Nanchang 209
Helsinki 174
Shenyang 160
Málaga 117
Dong Ket 113
Norwalk 109
Moscow 104
Hebei 94
New York 93
Tianjin 93
Florence 77
Jiaxing 77
Changsha 76
Kunming 75
Lancaster 75
Düsseldorf 74
Milan 72
Dearborn 68
London 66
Brussels 62
Falls Church 61
Jinan 58
Izmir 53
Shanghai 46
Hangzhou 45
Rome 44
San Francisco 38
Zhengzhou 37
Ningbo 35
Guangzhou 31
Los Angeles 30
Fremont 29
Toronto 29
Venezia 26
Washington 26
Abidjan 25
Amsterdam 25
Kilburn 22
Lanzhou 22
Santa Clara 21
Taizhou 21
Tappahannock 21
Edinburgh 20
Munich 20
Pisa 20
Renton 18
Brno 17
Central 16
Changchun 16
Frankfurt am Main 16
Redwood City 16
Haikou 14
Lucca 14
Vienna 14
Belgrade 13
Hefei 13
Hounslow 13
Phoenix 13
Skopje 13
Stockholm 13
Chicago 12
Hong Kong 12
Mestre 12
Sarzana 12
Melbourne 11
Turin 11
Bologna 10
Bonndorf 10
Chiswick 10
Indiana 10
Lappeenranta 10
Livorno 10
Waanrode 10
Bari 9
Canberra 9
Catania 9
Cedar Knolls 9
Prescot 9
Sacramento 9
Totale 36.287
Salva come PNG Salva come JPEG
Nome #
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients 730
Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. 513
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 399
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis 385
Hemodynamic evaluation of the optic nerve head in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 304
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment 298
A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL 280
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 227
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 219
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 215
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 207
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: Update on clinical, diagnostic, and management aspects 207
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 207
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 192
Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 189
Toscana itaca (Italian CADASIL) registry: an implementable online database for CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). 188
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis 186
SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI 186
Diffuse brain damage in normal tension glaucoma 185
Chemical pathology of acute demyelinating lesions and its correlation with disability 183
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 182
null 182
A new missense mutation in caveolin-3 gene causes rippling muscle disease. 181
Vitamin E deficiency secondary to chronic intestinal malabsorption and effect of vitamin supplement: a case report 178
Primary Progressive Multiple Sclerosis Evolving from Radiologically Isolated Syndrome 177
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 175
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 174
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. 174
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 174
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 172
A Rett syndrome MECP2 mutation that causes mental retardation in men 169
Fingolimod effect on brain volume loss independently contributes to its effect on disability 168
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 168
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes 167
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 166
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 166
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders 166
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder 164
DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study 164
Optic atrophy in Marinesco-Sjögren syndrome: an additional ocular feature. Report of three cases in two families 163
Progression of regional grey matter atrophy in multiple sclerosis 163
Structural and functional brain changes beyond visual system in patients with advanced glaucoma 163
Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency 163
A novel approach with “skeletonised MTR” measures tract-specific microstructural changes in early primary-progressive MS 162
Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 162
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: A large-scale, multicentre study 160
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 160
A new family with CADASIL: presentation of an homozygous patient and comparison with heterozigous phenotypes. 160
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 159
Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease 158
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 158
Cortical lesions in radiologically isolated syndrome. 157
[(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis 157
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS 157
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 157
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis. 156
Early structural changes in individuals at risk of familial Alzheimer's disease. A volumetry and magnetization transfer MR imaging study 156
Pathogenesis of multiple sclerosis: Insights from molecular and metabolic imaging 156
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 154
Blood–brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutations 154
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 153
Assessing response to interferon-β in a multicenter dataset of patients with MS 152
A human post-mortem brain model for the standardization of multi-centre MRI studies 151
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 150
Early changes of brain connectivity in primary open angle glaucoma 150
A rare association of myasthenia gravis and mitochondrial myopathy: a clinical, biochemical and morphologic study of one case 150
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 149
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 149
GABA: A new imaging biomarker of neurodegeneration in multiple sclerosis? 149
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 149
Scoring treatment response in patients with relapsing multiple sclerosis 149
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS 149
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 149
CADASIL and cerebrovascular diseases 148
Automated identification of brain new lesions in multiple sclerosis using subtraction images 147
N-acetylaspartate: usefulness as an indicator of viable neuronal tissue 146
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study 146
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 145
Increased QT variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 145
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 145
Merosin positive congenital muscular dystrophy with severe involvement of the central nervous system 144
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 144
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. 143
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study 143
Association of myopathy with multiple exostoses and mental retardation: a case report 142
Reproducibility of fMRI in the clinical setting: implications for trial designs 142
Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients 142
MRI criteria for MS in patients with clinically isolated syndromes 141
Retinal nerve fiber layer thinning in CADASIL: an optical coherence tomography and MRI study. 141
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 141
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis 141
Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies 140
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 140
Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis 139
Adult-onset Niemann-Pick type C disease: a clinical, neuroimaging and molecular genetic study 139
The spectrum of NOTCH3 mutation and phonotype variability in fourteen Italian families with CADASIL. 136
Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation 136
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations 136
Time to first relapse as an endpoint in multiple sclerosis clinical trials 136
Magnetization Transfer Imaging Demonstrates a Distributed Pattern of Microstructural Changes of the Cerebral Cortex in Amyotrophic Lateral Sclerosis 135
Totale 17.874
Salva come PNG Salva come JPEG
Categoria #
all - tutte 154.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.799
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.278 0 0 0 0 1.015 848 855 1.227 814 751 211 557
2020/20217.676 295 814 189 636 278 847 865 1.253 772 536 701 490
2021/20225.254 333 718 429 298 259 203 316 174 264 528 663 1.069
2022/20236.907 437 358 820 999 695 1.432 113 632 830 176 257 158
2023/20244.219 228 129 336 134 120 1.199 1.510 148 27 64 48 276
2024/20252.943 313 541 794 1.169 126 0 0 0 0 0 0 0
Totale 48.829